Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,751–3,775 of 7,816 matching trials · page 151 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
TapTalkTest Project:Development of a Non-invasive Screening Test to Detect Risk of Alzheimer's Disease Pathology NCT06114914 Tap Talk online program Runs in: Australia · 1 site |
NA other |
UNKNOWN | 1,000 | University of Tasmania OTHER |
2023-11-14 |
|
Ecological Assessment of Autonomy and Apathy NCT01661660 observationnal Runs in: France · 1 site |
NA other |
COMPLETED | 126 | Centre Hospitalier Universitaire de Nice OTHER |
2023-11-13 |
|
Skills-training for Reducing Risky Alcohol Use in App Form NCT03696888 Telecoach; TeleCoach control Runs in: Sweden · 1 site |
NA other |
COMPLETED | 678 | Karolinska Institutet OTHER |
2023-11-13 |
|
Evaluation of Cognitive State in Senior Subjects Using Neurosteer EEG System NCT04683835 Neurosteer Aurora system Runs in: Israel · 1 site |
NA other |
COMPLETED | 80 | Neurosteer Ltd. INDUSTRY |
2023-11-13 |
|
40Hz tACS in Treating Cognitive Function and Modulating Neurophysiology of Patients With Alzheimer's Disease NCT05723172 active tACS; sham tACS Runs in: Taiwan · 1 site |
NA other |
UNKNOWN | 48 | Che-Sheng Chu OTHER |
2023-11-13 |
|
Clinical Study of GKT in Diabetes Related Dementia NCT05855863 Ginkgo Ketone Ester Tablets; placebo |
PHASE4 other |
UNKNOWN | 370 | Shanghai 10th People's Hospital OTHER |
2023-11-13 |
|
Examination of Quantitative Electroencephalographic (QEEG) Biomarkers in Huntington's Disease NCT00670709 Runs in: United States · 1 site |
NA other |
COMPLETED | 42 | University of California, Los Angeles OTHER |
2023-11-09 |
|
Imaging Tau Deposition in the Brain of Elderly Subjects NCT02958670 18F-AV-1451 (Tau-PET tracer) Runs in: Switzerland · 1 site |
NA other |
ACTIVE_NOT_RECRUITING | 141 | University of Zurich OTHER |
2023-11-09 |
|
Enhanced Quality in Primary Care for Elders With Diabetes and Dementia NCT03723707 EQUIPED-ADRD Intervention; Control (CON) Runs in: United States · 1 site |
NA other |
COMPLETED | 355 | NYU Langone Health OTHER |
2023-11-09 |
|
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease NCT05908695 GV-971; Placebo Runs in: China · 50 sites |
PHASE4 other |
RECRUITING | 1,312 | Green Valley (Shanghai) Pharmaceuticals Co., Ltd. INDUSTRY |
2023-11-09 |
|
Acute Effect of Lemborexant on CSF Amyloid-Beta and Tau NCT05728736 Lemborexant 25 mg; Placebo Runs in: United States · 1 site |
PHASE2 other |
WITHDRAWN | 0 | Brendan Lucey OTHER |
2023-11-08 |
|
CogT BEEM Study (a tDCS Study) NCT04099524 tDCS Runs in: United States · 1 site |
NA other |
COMPLETED | 40 | University of Rochester OTHER |
2023-11-07 |
|
Age and Number of Previous Anesthesia on the Development of Mild Cognitive Decline (MCI) NCT04182477 Montreal Cognitive Assessment Runs in: Italy · 1 site |
NA other |
COMPLETED | 168 | University of Padova OTHER |
2023-11-07 |
|
Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment NCT06029920 Overground Walking Runs in: Indonesia · 1 site |
NA other |
COMPLETED | 15 | Universitas Padjadjaran OTHER |
2023-11-07 |
|
Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine NCT06116084 Ericksonian Hypnosis; Hypnosis Runs in: France · 1 site |
NA other |
UNKNOWN | 100 | Central Hospital, Nancy, France OTHER |
2023-11-03 |
|
Brain Insulin Resistance in Mild Cognitive Impairment NCT06116188 FDG-PET study Runs in: Finland · 1 site |
NA other |
UNKNOWN | 40 | Turku University Hospital OTHER_GOV |
2023-11-03 |
|
Rhythmically Entrained Exercise in Community-Dwelling Older Adults NCT05462977 Group exercise program Runs in: United States · 1 site |
NA other |
COMPLETED | 18 | University of North Carolina, Greensboro OTHER |
2023-11-02 |
|
A Systems Approach to Falls and Discharge Planning NCT03958994 Qualitative interviews Runs in: United Kingdom · 1 site |
NA other |
COMPLETED | 52 | Bournemouth University OTHER |
2023-11-01 |
|
Cognitive Screening and Cognitive Training in Seniors NCT02588209 Strategic Memory Advanced Reasoning Training; Brain Health Workshop Runs in: United States · 1 site |
NA other |
COMPLETED | 71 | The University of Texas at Dallas OTHER |
2023-10-30 |
|
Brain and Cognitive Changes After Reasoning Training in Individuals With Mild Cognitive Impairment NCT02596906 tDCS; Sham tDCS Runs in: United States · 1 site |
NA other |
COMPLETED | 22 | The University of Texas at Dallas OTHER |
2023-10-30 |
|
Cognitive Training in Mild Cognitive Impairment NCT04899089 Cognitive Training; Trivia Training Runs in: United States · 1 site |
NA other |
COMPLETED | 48 | University of Missouri-Columbia OTHER |
2023-10-30 |
|
TAS Test: Online Motor-cognitive Tests for Early Detection of Alzheimer's Disease NCT05194787 Cognitive test scores, clinical diagnosis and blood biomarkers Runs in: Australia · 1 site |
NA other |
RECRUITING | 3,000 | University of Tasmania OTHER |
2023-10-30 |
|
Intranasal Insulin in Frontotemporal Dementia (FTD) NCT04115384 Novolin-R insulin Runs in: United States · 1 site |
PHASE2 other |
TERMINATED | 3 | HealthPartners Institute OTHER |
2023-10-27 |
|
Triage Survey for Neurology Research Eligibility NCT06104852 Survey; Optional Medication Washout Runs in: United States · 3 sites |
NA other |
RECRUITING | 600 | Adams Clinical NETWORK |
2023-10-27 |
|
COGNIFOOD-Changing the Carbohydrate/Fat-ratio to Prevent Cognitive Decline and Alzheimer Pathology: A Pilot Study NCT06105320 LCHF; HCLF Runs in: Sweden · 1 site |
NA other |
UNKNOWN | 40 | Karolinska University Hospital OTHER |
2023-10-27 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial